drugset / Trial / NCT07357519
Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a multi-center, non-randomized, open-label, dosimetry and dose-escalation, cohort-expansion study of LNTH-2403 administered to subjects with relapsed / refractory (R/R) osteosarcoma. This study consists of 2 phases: (1) a dosimetry and dose escalation phase; and (2) a cohort expansion phase.
Timeline
- Start
- 2026-02-03
- Primary completion
- 2027-08
- Completion
- 2032-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LNTH-2403 | Monoclonal antibody | — | — |